Cargando…

Polymorphism FXII 46C>T and cardiovascular risk: additional data from Spanish and Tunisian patients

BACKGROUND: Previous studies showed an association between Coagulation Factor XII 46C>T polymorphism and variation in FXII plasma levels, as 46C>T seems to affect the translation efficiency. Case-control studies in Spanish samples indicated that genotype T/T is an independent risk factor for v...

Descripción completa

Detalles Bibliográficos
Autores principales: Athanasiadis, Georgios, Esteban, Esther, Vidal, Magdanela Gayà, Torres, Robert Carreras, Bahri, Raoudha, Moral, Pedro
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2732920/
https://www.ncbi.nlm.nih.gov/pubmed/19646235
http://dx.doi.org/10.1186/1756-0500-2-154
_version_ 1782171084092604416
author Athanasiadis, Georgios
Esteban, Esther
Vidal, Magdanela Gayà
Torres, Robert Carreras
Bahri, Raoudha
Moral, Pedro
author_facet Athanasiadis, Georgios
Esteban, Esther
Vidal, Magdanela Gayà
Torres, Robert Carreras
Bahri, Raoudha
Moral, Pedro
author_sort Athanasiadis, Georgios
collection PubMed
description BACKGROUND: Previous studies showed an association between Coagulation Factor XII 46C>T polymorphism and variation in FXII plasma levels, as 46C>T seems to affect the translation efficiency. Case-control studies in Spanish samples indicated that genotype T/T is an independent risk factor for venous thrombosis, ischemic stroke and acute coronary artery disease. In this study, we tried to reaffirm the importance of 46C>T in two samples from Spain and Tunisia. FINDINGS: A Transmission Disequilibrium Test (TDT) based on 101 family trios from Barcelona with one offspring affected by ischemic heart disease and a classical case-control study based on 76 patients with IHD and 118 healthy individuals from North and Centre-South Tunisia were conducted. Subjects were genotyped for 46C>T and data were analyzed accordingly, revealing no association in any of the two samples (TDT: P = 0.16, relative risk 1.17; case-control study: P = 0.59, odds ratio 1.36). CONCLUSION: The results suggest that 46C>T is not a risk factor for ischemic heart disease in any of the two analyzed samples and therefore the polymorphism seems not to be a universal risk factor for cardiovascular diseases.
format Text
id pubmed-2732920
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27329202009-08-28 Polymorphism FXII 46C>T and cardiovascular risk: additional data from Spanish and Tunisian patients Athanasiadis, Georgios Esteban, Esther Vidal, Magdanela Gayà Torres, Robert Carreras Bahri, Raoudha Moral, Pedro BMC Res Notes Short Report BACKGROUND: Previous studies showed an association between Coagulation Factor XII 46C>T polymorphism and variation in FXII plasma levels, as 46C>T seems to affect the translation efficiency. Case-control studies in Spanish samples indicated that genotype T/T is an independent risk factor for venous thrombosis, ischemic stroke and acute coronary artery disease. In this study, we tried to reaffirm the importance of 46C>T in two samples from Spain and Tunisia. FINDINGS: A Transmission Disequilibrium Test (TDT) based on 101 family trios from Barcelona with one offspring affected by ischemic heart disease and a classical case-control study based on 76 patients with IHD and 118 healthy individuals from North and Centre-South Tunisia were conducted. Subjects were genotyped for 46C>T and data were analyzed accordingly, revealing no association in any of the two samples (TDT: P = 0.16, relative risk 1.17; case-control study: P = 0.59, odds ratio 1.36). CONCLUSION: The results suggest that 46C>T is not a risk factor for ischemic heart disease in any of the two analyzed samples and therefore the polymorphism seems not to be a universal risk factor for cardiovascular diseases. BioMed Central 2009-07-31 /pmc/articles/PMC2732920/ /pubmed/19646235 http://dx.doi.org/10.1186/1756-0500-2-154 Text en Copyright © 2009 Moral et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Report
Athanasiadis, Georgios
Esteban, Esther
Vidal, Magdanela Gayà
Torres, Robert Carreras
Bahri, Raoudha
Moral, Pedro
Polymorphism FXII 46C>T and cardiovascular risk: additional data from Spanish and Tunisian patients
title Polymorphism FXII 46C>T and cardiovascular risk: additional data from Spanish and Tunisian patients
title_full Polymorphism FXII 46C>T and cardiovascular risk: additional data from Spanish and Tunisian patients
title_fullStr Polymorphism FXII 46C>T and cardiovascular risk: additional data from Spanish and Tunisian patients
title_full_unstemmed Polymorphism FXII 46C>T and cardiovascular risk: additional data from Spanish and Tunisian patients
title_short Polymorphism FXII 46C>T and cardiovascular risk: additional data from Spanish and Tunisian patients
title_sort polymorphism fxii 46c>t and cardiovascular risk: additional data from spanish and tunisian patients
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2732920/
https://www.ncbi.nlm.nih.gov/pubmed/19646235
http://dx.doi.org/10.1186/1756-0500-2-154
work_keys_str_mv AT athanasiadisgeorgios polymorphismfxii46ctandcardiovascularriskadditionaldatafromspanishandtunisianpatients
AT estebanesther polymorphismfxii46ctandcardiovascularriskadditionaldatafromspanishandtunisianpatients
AT vidalmagdanelagaya polymorphismfxii46ctandcardiovascularriskadditionaldatafromspanishandtunisianpatients
AT torresrobertcarreras polymorphismfxii46ctandcardiovascularriskadditionaldatafromspanishandtunisianpatients
AT bahriraoudha polymorphismfxii46ctandcardiovascularriskadditionaldatafromspanishandtunisianpatients
AT moralpedro polymorphismfxii46ctandcardiovascularriskadditionaldatafromspanishandtunisianpatients